CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Clinical trial NCT00109967 · COMPLETED

Trial details

NCT number: NCT00109967
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Mantle Cell Lymphoma

Start date: 2005-05-01
Primary completion: 2009-09-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.